Pooling, meta-analysis, and the evaluation of drug safety
<p>Abstract</p> <p>Background</p> <p>The "integrated safety report" of the drug registration files submitted to health authorities usually summarizes the rates of adverse events observed for a new drug, placebo or active control drugs by pooling the safety dat...
Main Authors: | Leizorovicz Alain, Cucherat Michel, Lièvre Michel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-03-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Online Access: | http://cvm.controlled-trials.com/content/3/1/6 |
Similar Items
-
Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.
by: Sylvain Rheims, et al.
Published: (2008-08-01) -
Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis.
by: Benjamin Castagné, et al.
Published: (2019-01-01) -
The incubation period of COVID-19: A meta-analysis
by: Christelle Elias, et al.
Published: (2021-03-01) -
Systematic review and meta-analysis of diagnostic accuracy of loop-mediated isothermal amplification (LAMP) methods compared with microscopy, polymerase chain reaction and rapid diagnostic tests for malaria diagnosis
by: Stephane Picot, et al.
Published: (2020-09-01) -
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening
by: Penfornis Alfred, et al.
Published: (2011-01-01)